Robert J H, Hoffmeyer P, Broquet P E, Cerutti P, Vasey H
Orthopaedic Clinic, Hôpital Cantonal Universitaire, de Geneva, Switzerland.
Orthop Rev. 1993 May;22(5):567-71.
Twenty cases of clinically patent fat embolism syndrome (FES) were observed at the authors' institution between 1964 and 1989. There were 4 deaths (20%). The injury severity score (ISS) was computed for each patient upon admission and ranged from 9 to 50 (median, 17). The ISS was significantly higher in the 4 deceased patients (P = .014). The incidence of FES amounted to 0.26% of all patients hospitalized with at-risk fractures (femoral and tibial shaft fractures and pelvic fractures). The findings of the 25-year study indicate the following: (1) clinically patent postfracture FES is rare; (2) FES is significantly more frequent in patients with several at-risk fractures than in those with one at-risk fracture (P < .0003); and (3) prognosis appears to be more directly related to ISS than to FES itself.
1964年至1989年间,作者所在机构观察到20例临床确诊的脂肪栓塞综合征(FES)病例。其中4例死亡(20%)。每位患者入院时均计算损伤严重程度评分(ISS),范围为9至50(中位数为17)。4例死亡患者的ISS显著更高(P = 0.014)。FES的发病率占所有因高危骨折(股骨干和胫骨干骨折以及骨盆骨折)住院患者的0.26%。这项长达25年的研究结果表明:(1)骨折后临床确诊的FES很罕见;(2)有多处高危骨折的患者发生FES的频率明显高于有一处高危骨折的患者(P < 0.0003);(3)预后似乎与ISS的关系比与FES本身的关系更直接。